Literature DB >> 19106904

[Atopic dermatitis aggravates the allergic airways inflammation in acute viral bronchiolitis].

D Marchand1, N Tayara, M-L Choukroun, A Sarrat, H Guenard, J-L Demarquez, J-M Tunon De Lara, M Fayon.   

Abstract

INTRODUCTION: Exhaled nitric oxide (FeNO) is a putative non-invasive marker of eosinophilic airway inflammation with a good predictive value for allergic asthma in preschool children. The aim of the present study was to compare FeNO after acute viral bronchiolitis (AVB) in children aged less than 2 years without atopic dermatitis (AD) vs those with atopic dermatitis, as well as children with AD without any history of AVB.
METHODS: Forty-two children (mean age +/- SD: 12.3 +/- 5.2 months; range 5.0-23.5; sex-ratio M: F=1.3: 1) were included in this prospective study, > 8 wks after an episode of AVB. The patients' atopic status was assessed both by clinical phenotype and IgE- mediated response to inhaled and/or food allergens. FeNO (ppb) was measured off-line by the chemoluminescence method on samples obtained from gas collected in a balloon during tidal breathing.
RESULTS: There was a significant difference between the AVB/AD (23.4 +/- 14.3 ppb, n=15) vs the AVB without AD group (13.5 +/- 10. 1 ppb, n=13) or the AD without AVB group (11.0 +/- 8.3 ppb, n=14). Maternal feeding for more than 2 months decreased FeNO by 50%.
CONCLUSION: Atopic children below 2 years with AD produce more NO after AVB than non-atopic children or atopic children without any history of AVB. Maternal feeding decreases FeNO.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19106904     DOI: 10.1016/s0761-8425(08)74978-7

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  2 in total

1.  Predictors of Inappropriate Use of Diagnostic Tests and Management of Bronchiolitis.

Authors:  Lorena Sarmiento; Gladys E Rojas-Soto; Carlos E Rodríguez-Martínez
Journal:  Biomed Res Int       Date:  2017-07-03       Impact factor: 3.411

Review 2.  For which infants with viral bronchiolitis could it be deemed appropriate to use albuterol, at least on a therapeutic trial basis?

Authors:  Carlos E Rodríguez-Martínez; Gustavo Nino; Jose A Castro-Rodriguez; Ranniery Acuña-Cordero; Monica P Sossa-Briceño; Fabio Midulla
Journal:  Allergol Immunopathol (Madr)       Date:  2021-01-02       Impact factor: 1.667

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.